Richard T. Kenney

Chief Medical Officer at Sonnet BioTherapeutics Holdings · 7 reported transactions in 1 company · latest report Dec 2, 2025

Their trades


Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 163,760 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Exercised options — · 163,760 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 69,614 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Shares withheld for tax — · 16,891 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Exercised options — · 86,505 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 9,374 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Share award — · 8,000 shares	Jul 11, 2025

Dec 2, 2025 · SONN

163,760

Dec 2, 2025 · SONN

163,760

Dec 2, 2025 · SONN

69,614

Dec 2, 2025 · SONN

16,891

Dec 2, 2025 · SONN

86,505

Dec 2, 2025 · SONN

9,374

Jul 11, 2025 · SONN

8,000

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Medical Officer at Sonnet BioTherapeutics Holdings · 7 reported transactions in 1 company · latest report Dec 2, 2025


Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 163,760 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Exercised options — · 163,760 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 69,614 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Shares withheld for tax — · 16,891 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Exercised options — · 86,505 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Returned to company — · 9,374 shares	Dec 2, 2025
Sonnet BioTherapeutics HoldingsSONN	Share award — · 8,000 shares	Jul 11, 2025